We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for molnupiravir (Merck Sharp & Dohme (Australia) Pty Ltd)
Active ingredients
molnupiravir
Date of review outcome
Lapse date
Type
Provisional approval
Indication
For treatment of COVID-19 in adults
Therapeutic area
Infectious diseases